Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 11;9(9):1013.
doi: 10.3390/vaccines9091013.

Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports

Affiliations
Review

Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports

Konstantinos Katsikas Triantafyllidis et al. Vaccines (Basel). .

Abstract

The newly developed COVID-19 vaccines have established a safe profile, yet some individuals experience a wide range of adverse events. Recently, reactivation of varicella zoster virus (VZV) has been observed after administration of different COVID-19 vaccines, although causality remains a matter of debate. The aim of this systematic review was to examine the available literature and provide an overview of reported cases of VZV reactivation following COVID-19 vaccination. We identified 12 eligible articles which included 91 patients with herpes zoster (HZ) following COVID-19 vaccination. Hypertension was the main comorbidity present in 18% of patients (16/91). Additionally, 13% of patients (12/91) had an autoimmune condition with rheumatoid arthritis being the most common (4/12). Moreover, 10% of patients (9/91) were receiving immunosuppressants. The dermatomal distribution of skin lesions varied among patients, with the mammary region being most affected. On average, symptoms developed 5.8 days post-vaccination irrespective of dose and treatment with oral valacyclovir as a monotherapy was employed in most patients (23/91). HZ is possibly a condition clinicians may expect to encounter in patients receiving COVID-19 vaccines. While causality has not yet been established increased awareness and early recognition of the disorder would be crucial for the optimal management of these patients.

Keywords: COVID-19 vaccine; SARS-CoV-2; Varicella zoster virus; case reports; case series; coronavirus; herpes zoster; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Prisma flowchart. IPD: Individual Patient Data.

References

    1. Lu H., Stratton C.W., Tang Y.W. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J. Med. Virol. 2020;92:401–402. doi: 10.1002/jmv.25678. - DOI - PMC - PubMed
    1. Yang X., Yu Y., Xu J., Shu H., Liu H., Wu Y., Zhang L., Yu Z., Fang M., Yu T. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8:475–481. doi: 10.1016/S2213-2600(20)30079-5. - DOI - PMC - PubMed
    1. Nicola M., Alsafi Z., Sohrabi C., Kerwan A., Al-Jabir A., Iosifidis C., Agha M., Agha R. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int. J. Surg. 2020;78:185–193. doi: 10.1016/j.ijsu.2020.04.018. - DOI - PMC - PubMed
    1. Loubet P., Wittkop L., Tartour E., Parfait B., Barrou B., Blay J.-Y., Hourmant M., Lachâtre M., Laplaud D.-A., Laville M. A French cohort for assessing COVID-19 vaccine responses in specific populations. Nat. Med. 2021;27:1319–1321. doi: 10.1038/s41591-021-01435-1. - DOI - PubMed
    1. Johnson J. Johnson & Johnson COVID-19 Vaccine Authorized by US FDA For Emergency Use-First Single-Shot Vaccine in Fight Against Global Pandemic. Johnson & Johnson; New Brunswick, NJ, USA: 2021.

LinkOut - more resources